KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) EBT (2016 - 2025)

Amgen (AMGN) has 17 years of EBT data on record, last reported at $1.5 billion in Q4 2025.

  • For Q4 2025, EBT rose 93.61% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $9.0 billion, up 94.75%, while the annual FY2025 figure was $9.0 billion, 94.75% up from the prior year.
  • EBT reached $1.5 billion in Q4 2025 per AMGN's latest filing, down from $3.9 billion in the prior quarter.
  • Across five years, EBT topped out at $3.9 billion in Q3 2025 and bottomed at -$68.0 million in Q1 2024.
  • Average EBT over 5 years is $1.8 billion, with a median of $1.7 billion recorded in 2022.
  • Peak YoY movement for EBT: tumbled 101.98% in 2024, then surged 3001.47% in 2025.
  • A 5-year view of EBT shows it stood at $2.1 billion in 2021, then dropped by 17.97% to $1.7 billion in 2022, then crashed by 51.26% to $852.0 million in 2023, then fell by 8.22% to $782.0 million in 2024, then soared by 93.61% to $1.5 billion in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $1.5 billion in Q4 2025, $3.9 billion in Q3 2025, and $1.6 billion in Q2 2025.